Form 4: Marinus Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Christina Shafer, Chief Commercial Officer of Marinus Pharmaceuticals, sold 3,820 shares of common stock on August 5, 2024, to cover tax obligations related to vesting restricted stock units.

Summary

• On August 5, 2024, Christina Shafer, the Chief Commercial Officer of Marinus Pharmaceuticals, sold 3,820 shares of the company's common stock.
• The sale was executed at a weighted-average price of $1.14 per share, with individual transactions ranging from $1.11 to $1.16.
• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 16, 2022.
• The purpose of the sale was to cover tax obligations associated with the vesting of restricted stock units.
• Following the transaction, Shafer directly owns 67,406 shares of Marinus Pharmaceuticals.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive to cover tax obligations. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by company executives are a normal part of corporate governance. The sale was conducted under a pre-arranged 10b5-1 trading plan, which is a common practice to avoid accusations of insider trading.

Key Dates

Keywords

Marinus Pharmaceuticals, MRNS, Christina Shafer, Chief Commercial Officer, stock sale, Form 4, Rule 10b5-1, insider trading, tax obligations, restricted stock units